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1. Introduction
Melanocytes are special pigment cells that reside predominantly in the skin and eyes. In the
skin, melanocytes are located in the bottom layer (the stratum basale) of the skin's epidermis
and in the hair follicles (Gray-Schopfer et al., 2001). Melanocytes produce melanins responsible
for skin and hair color and perform protection function of the basal keratinocytes from
ultraviolet light through synthesis and donation of melanin (Gray-Schopfer et al., 2001).
Melanocytes maintain constant contact with the basal layer of the epidermis through direct
interaction with basal keratinocytes and via secretion of soluble factors. Upon ultraviolet
radiation, keratinocytes produce factors that control melanocyte proliferation, differentiation
and motility (Gray-Schopfer et al., 2007). Melanocytes maintain during a lifetime a stable-ratio
of 1:5 with basal keratinocytes (Fitzpatrick et al., 1979).
Initially, cutaneous melanocytes originate from neural crest cells and migrate into the skin
during embryonic development. Neural crest cells start their migration from the neural tube
shortly after the closure of the neural tube. These cells migrate along several well-defined
pathways in a ventral direction from the neural tube through the somites. As the epithelial
somites undergo a transition to form the dermatome (presumptive dermis), myotome (pre‐
sumptive muscle), and sclerotome (presumptive vertebrae), most ventrally migrating neural
crest cells invade the rostral half of each sclerotome and avoid the caudal (posterior) part of
© 2013 Rubina et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
each sclerotome (Rickmann et. al., 1985; Teillet et al., 1987; Serbedzua et al., 1989; Ranscht and
Bronner, 1991).
Originated from a population of highly motile neural crest progenitors, melanocytes protect
basal keratinocytes, in the skin. At the same time, they could become precursors of the most
dangerous form of cancer - melanoma. Skin cancer including the most frequently occurring
forms such as basal cell carcinoma, squamous cell carcinoma and melanoma, is one of the most
common human malignancies. Today melanoma is one the fastest growing malignancies. The
high propensity of melanoma to form metastasis is the most important feature that distin‐
guishes melanoma from other types of skin cancers. According to the World Health Organi‐
zation, melanoma accounts for only 25% of skin cancers. However, it is the most dangerous
form of skin cancer leading to high mortality. If diagnosed early it can be successfully removed
by surgical resection and about 80% of cases are cured this way (Gray-Schopfer et al., 2001).
However, at progressed metastatic stages melanoma is highly resistant to currently existing
therapies and has a very poor prognosis. This area requires future research to understand
melanoma biology and develop new therapeutic solutions.
Melanoma begins as a benign naevus but can quickly progress to the malignant stage (Bar-Eli.,
1997; Luca and Bar-Eli., 1998). Herewith melanocytes start to proliferate and spread, which
can be limited to the epidermis (junctional naevus), or the dermis (dermal naevus) or both
(compound naevus) (Gray-Schopfer et al., 2001). Naevi can progress to the radial-growth-
phase (RGP) melanoma which is an intra-epidermal lesion with sporadic local microinvasion
into the underlying derma. However, RGP melanoma can transform into the vertical-growth
phase (VGP) melanoma with a higher invasive potential in which melanoma cells from tumor
nodules or nests invade the underlying derma. Finally, melanoma can develop metastases after
the vertical growth phase (Clark et al., 1984). Not all melanomas pass through each of these
phases and can progress from isolated melanocytes or naevi, while both, RGP or VGP, can
develop directly into metastatic malignant melanoma (Miller et al., 2006). Four main clinical
subtypes of melanoma are described (Clark et al., 1984). Superficial spreading melanoma
(SSM) is the most common form and it is associated with severe sunburns, especially at an
early age (Ishihara et al., 2001; Gilchrest et al., 1999). In most cases, SSM is flat, with intra-
epidermal microinvasion, particularly at the edges of the lesion. Nodular melanoma comprises
raised nodules and has almost no flat parts. Acral lentiginous melanoma (ALM) is not linked
to UV exposure and is usually found on the palms of the hands, soles of the feet and in the nail
bed (Kuchelmeister et al., 2000). Lentigo maligna appears to be flat and is associated with
chronic sun exposure in elderly people.
2. Cadherin-mediated adhesion in melanoma progression
Tumor progression is characterized by uncontrolled cell proliferation, high invasive potential
into surrounding tissue and metastasis to distant organs. It is believed that this is largely due
to disruption or dysfunction of intercellular contacts (Hanahan and Weinberg, 2000). Cadher‐
ins comprise a large family of Ca2+-dependent adhesion molecules (Angst et al., 2001; Gumbin‐
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er, 2005) and are involved in tissue and organ development durig embryogenesis and
maintainance of the normal cell arrangement in the adult organism. The regulation of cadherin
expression patterns and their activity at the neural crest-forming area plays a critical role in
emigration of melanocyte precursors - neural crest cells from the neural tube (Nakagawa and
Takeichi, 1998).
Cadherins play an important role in specific cell-cell adhesion, cell recognition and signaling
(Angst et al., 2001; Gumbiner, 2005; Wheelock and Johnson, 2003). Cadherins are transmem‐
brane glycoproteins with their extracellular part responsible for homotypic binding between
the neighboring cells, while intracellular part is involved in anchoring cadherins to the cytoske‐
leton. Cadherins interact with the cytoskeleton via catenins (alfa and beta catenins and p120)
and form a multicomponent complex which also comprises a number of regulatory molecules
such as protein tyrosine kinase, protein tyrosine phosphatase and small GTPases (Perez-
Moreno et al., 2003; Sallee et al., 2006; Gumbiner, 2005; Vincent et al., 2004; Rubina et al., 2007).
Disruption of cadherin adherent junctions and their dysfunction has been associated with
tumor cell invasion and metastasis (Takeichi, 1993). In human carcinoma the loss of E-cadherin
expression leads to dedifferentiation and increased invasiveness of carcinoma cells (Frixen et
al., 1991). The change in the expression pattern of cadherins in melanocytes from E-cadherin,
P-cadherin and desmoglein to N-cadherin is associated with melanocyte transformation and
metastasis (Bonitsis et al., 2006). In normal skin, melanocytes project multiple extensions to
keratinocytes and form cadherin adhesive contacts with the basal keratinocytes, which control
maintain proliferation and correct positioning of melanocytes (Haas and Herlyng, 2005; Haass
et al., 2005). E-cadherin is mainly responsible fot these cell-cell interaction. The loss of func‐
tional E-cadherin or its downregulation let melanocytes escape form keratinocyte control and
correlates with high invasiveness and metastasis of the overlying melanoma cells (Hsu et al.,
1996; Silye et al., 1998).
Downregulation of E-cadherin and/or its dysfunction is one of the earliest steps in the
development of metastases in cutaneous melanoma (Johnson, 1999). E-cadherin expression is
detected in cultured melanocytes and naevus cells, while its expression is often lost in cultured
melanoma cells from the primary tumors or metastasis (Danen et al., 1996). In the radial growth
phase melanoma cells could retain expression of membrane E-cadherin (Sanders et al., 1999).
It was even noted that there is a correlation between E-cadherin expression and the depth of
the primary tumor (Andersen et al., 2004). Experiments on re-expression of E-cadherin using
adenoviral transfer of full length E-cadherin cDNA showed the reduction in tumorigenicity
and decrease in proliferation rate of melanoma cells (Hsu et al., 2000). The mechanism of E-
cadherin transcriptional downregulation in melanomas involves gene silencing by methyla‐
tion or transrepression by the Snail protein from a superfamily of zinc-finger transcription
factors (Tsutsumida et al., 2004). Thus it was suggested that E-cadherin could play an impor‐
tant role in the preventing the melanocytes transformation and limiting their proliferation
(cited in Bonitsis et al., 2006).
Catenins are a group of cadherin-associated molecules and they were also suggested to be
involved in malignant transformation of melanocytes. The change in catenin expression
pattern was found in melanocytic naevus and melanomas, where the expression of alfa and
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beta catenins was reduced or altered, while beta catenin was often overexpressed (Zhang and
Hersey., 1999). The loss of E-cadherin in melanocytes may also indirectly influence the β-
catenin cytoplasmic content and affects the β-catenin/wnt signaling pathways. Namely, the
reduction in the membranous E-cadherin resulted in the accumulation of free cytoplasmic β-
catenin which did not degrade in proteasomes and was translocated to the nucleus. Nuclear
β-catenin could be involved in regulation of gene expression responsible for growth and
metastasis control via β-catenin/wnt signaling pathways (McGary et al., 2002). Also the
presence of the functional E-cadherin in melanocytes ensured their correct adhesion to
keratinocytes and limited their motility and proliferation (Gruss et al., 2001; Tang et al., 1994).
Despite  the  majority  of  studies  showed a  correlation between the  decreased E-cadherin
expression and tumorigenicity of melanoma cells, there were data suggestintg that in some cases
E-cadherin expression could be retained or even elevated in melanoma (Ruiter and van Muijen,
1998; Nishizawa et al., 2005). It was reported that membranous E-cadherin was present in the
metastasizing melanomas and their corresponding lymph node metastasis (Silye et al., 1998).
The loss of E-cadherin expression in melanomas correlates with the increase in N-cadherin
expression. This change contributed to the survival advantage of melanoma cells and their
invasive and migratory properties (McGary et al., 2002). The shift in cadherin expression
pattern was found both in vivo and in vitro (Hsu et al., 1996; Hsu et al., 2000). It was suggested
that melanoma cells form N-cadherin adhesion contacts with fibroblasts, vascular endothelial
cells, and adjacent melanoma cells (Li and Herlyn, 2000). The N-cadherin-mediated adhesion
facilitated migration of melanoma cells over dermal fibroblasts and their transmigration into
the vascular system (Haass and Herlyn, 2005; Li et al., 2002) and induced formation of
communication gap junction between melanoma cells and the surrounding stroma (McGary
et al., 2002). Anti-N-cadherin antibodies retarded the transendothelial migration of melanoma
cells and induced their apoptosis, which linked the N-cadherin in the ability of melanoma cells
for diapedesis (Li et al., 2002; Sandig et al., 1997; Voura et al., 1998). Surprisingly, adenoviral
gene transfer of E-cadherin inhibited N-cadherin expression in melanoma cells and their
survival and migration (Hsu et al., 2000). At the same time N-cadherin overexpression did not
affect the endogenous E-cadherin expression (Li et al., 2001).
Little is known about the role of P-cadherin in the progression of malignant melanomas. P-
cadherin is expressed in basal keratinocytes, melanocytes, in the cells of the basal and outer
layers of skin appendages (Klymkowsky and Parr, 1995). As Similarly to E-cadherin, P-
cadherin was thought to be involved in the regulation of melanocyte proliferation and
migration (Klymkowsky and Parr, 1995). It was found that the soluble form of P-cadherin
missing the transmembrane and the cytoplasmic part was expressed in melanoma cells (Bauer
et al., 2005) and was associated with increasing tumor thickness and metastasis and reduced
patient survival (Bachmann et al., 2005).
VE-cadherin is another member of the cadherin superfamily, which was shown to be involved
in melanoma progression. VE-cadherin was found to be exclusively expressed on endothelial
cells in normal vessels and mediated homophilic contacts between neighboring cells regulating
endothelial barrier function (Dejana, 1996). VE-cadherin is essential for both the development
and the maintenance of blood vessels in the adult organism. In the embryo, VE-cadherin
Research Directions in Tumor Angiogenesis146
appeared at a very early stage of vascular development in mesodermal cells of yolk sac
mesenchyme; it was also expressed in progenitor cells during the early angioblast differentia‐
tion and endocardial development (Dejana et al., 2000; Cavallaro et al., 2006). At the later stages,
VE-cadherin expression was restricted to the peripheral layer of blood islands that give rise to
endothelial cells (Dejana et al., 2000).
VE-cadherin was also shown to be important for melanoma cell invasion and metastasis. At
the beginning of diapedesis, endothelial cells located below the attached melanoma cells
disassemble their VE-cadherin-mediated adhesion contacts. This allowed melanoma cell to
penetrate through the VE-cadherin-negative regions in the endothelial cell monolayer and
intercalate between endothelial cells. Subsequently, the endothelial cells surrounding the
melanoma cells extended processes and spread over melanoma. The leading edges of the
projections of endothelial cell expressed high levels of N-cadherin but not VE-cadherin. VE-
cadherin expression was restored when the endothelial cells met and reformed cell-cell
contacts above the melanoma cell (Voura et al., 1998). Highly aggressive human cutaneous
and uveal melanoma cells were also found to express VE-cadherin in contrast to less aggressive
cells (Hendrix et al., 2001). This expression contributed to the ability of melanoma cells to mimic
endothelial cells and form patterned networks of vascular channels (Hendrix et al., 2001;
Hendrix et al., 2003). These data indicated that melanoma cells cooperate with the endothelial
cells in the process of invasion and that the regulated changes in the expression of cadherins
played an essential role in melanoma growth and metastasis.
Thus, further studies are required to elucidate the biochemical and cellular mechanism of
melanoma transformation and progression and the role of cadherins in this process. Lately, an
atypical member of the cadherin superfamily – T-cadherin was was shown to be involved in
melanoma progression. However, its role and mechanism of action were not completely
understood.
3. T-cadherin in cancer
T-cadherin is a unique member of cadherin superfamily because it lacks the transmembrane
and cytoplasmic domains and is anchored to the cell membrane via a glycosyl-phosphatidy‐
linositol (GPI) moiety (Fredette and Ranscht, 1994; Fredette et al., 1996; Ranscht and Dours-
Zimmermann 1991). Although T-cadherin contains five Ca2+–binding domains on its N-
terminal end it does not have the His-Ala-Val motif responsible for the recognition and binding
of the classical cadherins. It was shown that T-cadherin can mediate week homophilic adhesion
in aggregation assays in vitro (Vestal and Ranscht, 1992; Resink et al., 1999) but the lack of
intracellular domain strongly suggested that Т-cadherin is not involved in stable сеll-сеll
adhesion. Moreover, T-cadherin was show to be absent from the adherent junctions and was
located within lipid rafts in the plasma membrane (Philippova et al., 1998); was redistributed
to the leading edge in migrating cells (Philippova et al., 2003). These imply T-cadherin as a
navigation receptor involved in transduction of extracellular cues in migrating cells rather than
an adhesion molecule.
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Little is known about the biological role and underlying mechanisms of T-cadherin in malig‐
nant transformation and tumor progression. In some reports, T-cadherin was regarded as a
tumor suppressor and its downregulation was associated with tumor progression. Downre‐
gulation of T-cadherin was shown to be associated also with tumorogenicity in breast (Riener
et al., 2008), lung (Sato et al., 1998), and gallbladder cancers (Adachi et al., 2009). However, in
other cancers such as ovarian, endometrial (Widschwendter et al., 2004; Suehiro et al., 2008)
and osteosarcoma (Zucchini et al., 2004), decreased expression of T-cadherin positively
correlated with patient survival. T-cadherin was upregulated in human invasive hepatocel‐
lular carcinomas (Riou et al., 2006) and astrocytomas (Gutmann et al., 2001).
T-cadherin is expressed in the basal layer of keratinocytes, in melanocytes and in vascular cells
of the dermal blood vessels in the normal skin (Zhou et al., 2002; Kuphal et al., 2009; Rubina
et al., 2012). However, its expression was consequently lost upon cell transformation and tumor
progression in pre-malignant skin lesions and in non-melanoma skin cancer. In skin lesions,
such as actinic keratosis T-cadherin was abundantly expressed in the atypical keratinocytes,
while its expression varied in Bowen disease and was weaker than in the normal skin (Pfaff et
al., 2010). Expression of T-cadherin was reduced in psoriatic samples (Zhou et al., 2003) and
was down-regulated or completely absent in invasive cutaneous squamous cell carcinoma
(Takeuchi et al., 2002a) and in basal cell carcinoma of the skin (Takeuchi et al., 2002b). Data
obtained in our lab supported these findings and confirmed that T-cadherin expression was
not changed if cells maintained the attachment to the basal membrane in the lesions charac‐
terized by slow or controlled keratinocytes growth (keratoacanthoma, psoriasis, actinic
keratosis and superficial basalioma) (Rubina et al., 2012). However, T-cadherin expression in
keratinocytes was downregulated upon tumor progression in basosquamous cell carcinoma,
squamous cell carcinoma and in some cases of basal cell carcinoma, i.e. tumors with high
proliferative, invasive, and metastatic potential (Rubina et al., 2012).
Apart from regulation of keratinocyte proliferation, T-cadherin may affect tumor progression
through its direct involvement in neovascularization. While in the normal blood vessels T-
cadherin was abundantly expressed in endothelial and mural cells (Ivanov et al., 2001), its
expression was altered in tumor vessels in Lewis carcinoma lung metastasis and F9 endoder‐
mal teratocarcinoma and in human xenografts PC-3 prostate cancer or A673 rhabdomyosar‐
coma (Riou et al., 2006; Wyder et al., 2000). Inactivation of T-cadherin gene limited mammary
tumor vascularization and reduced tumor growth in the mouse mammary tumor virus
(MMTV)-polyoma virus middle T (PyV-mT) transgenic model (Hebbard et al., 2008). In human
hepatocellular carcinoma (НСС) T-cadherin was also upregulated in intratumoral capillary
endothelial cells and this increase соrrеlаtеd with tumor growth and metastasis (Adachi et al.,
2006). Data obtained in our lab indicated that in pre-malignant skin lesions all blood vessels
uniformly expressed T-cadherin (Rubina et al., 2012). The aberrant expression of T-cadherin
and vascular markers was detected in aggressively developing skin tumors such as basosqu‐
amous cell carcinoma, squamous cell carcinoma and in some cases of basal cell carcinoma. We
suggested that the high level of expression of T-cadherin in the normal keratinocytes and in
benign tumors regulates the growth of blood vessels. Upon malignant transformation
expression of T-cadherin was lost in tumor cells and altered on vascular cells. This caused the
abnormality and excessive vascularization of the tumors (Rubina et al., 2012).
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The role of T-cadherin in melanoma progression and vascularization was addressed in a few
studies and the results were contradictory. T-cadherin was expressed in normal human skin
melanocytes (Kuphal et al., 2009; Bosserhoff et al., 2011). However, it was shown that the
precursors of melanocytes did not express T-cadherin and invaded T-cadherin negative rostral
parts of sclerotomes avoiding T-cadherin positive caudal parts of sclerotomes during neural
crest cell migration (Ranscht and Bronner-Fraser, 1991). These results led to a hypothesis that
T-cadherin is a navigating receptor that provides topographic guidance for migrating mela‐
nocyte precursors, and that de-differentiated or transformed melanocytes may loose T-
cadherin expression. Indeed, T-cadherin expression was found to be diminished in
melanocytes induced to de-differentiate to melanoblast-related cells and T-cadherin expres‐
sion was undetectable in about 80% of human melanoma cell lines (Kuphal et al., 2009;
Bosserhoff et al., 2011). While T-cadherin was expressed in benign naevus nests, its expression
was lost in most tissue samples of human primary melanoma, lymph and visceral melanoma
metastasis indicating the potential role of T-cadherin in melanoma progression (Kuphal et al.,
2009). In addition, T-cadherin re-expression by stable transfection in human melanoma cells
reduced the rate of tumor growth in the nu/nu mouse tumor model, decreased cell capacity
for anchorage-independent growth, and for migration and invasion in vitro (Kuphal et al.,
2009). However, it was shown in other studies that T-cadherin overexpression in endothelial
cells stimulated intratumoral angiogenesis in tumor co-culture spheroid model with melano‐
ma cells in vitro (Ghosh et al., 2007). Despite T-cadherin expression is lost in the majority of
melanoma cell lines, 20% of melanomas still express T-cadherin (Kuphal et al., 2009; Bosserhoff
et al., 2011) and possess invasive and metastatic potential.
To gain insights into the function of T-cadherin in melanoma progression and growth we first
examined T-cadherin expression in the normal human skin melanocytes, melanoma cells and
the blood vessels of the primary melanomas and melanoma metastasis in human samples and
in the experimental models.
4. T-cadherin expression in human melanoma
We performed a comparative study of T-cadherin expression in normal skin and in melanoma
samples. Tissue samples of primary human melanoma and metastasis obtained from patients
undergoing surgical treatment were immediately frozen with liquid nitrogen and stored at
-80oC. Human skin biopsies from healthy donors and melanoma samples of patients were
immunostained with antibodies against T-cadherin and vascular cell markers and analyzed
using fluorescent microscope.
Human skin biopsies from 6 healthy donors, 10 tissue samples of primary human melanoma
and 12 samples of visceral melanoma metastasis were obtained from Blokhin Russian Cancer
Research Center of Russian Academy of Medical Sciences. Consequent cryosections of the
samples (7µm thick) were fixed in 4% paraformaldehyde (PRS Panreac, Spain), whashed and
then incubated in a mixture of primary antibodies against T-cadherin (rabbit anti-human,
ProSci, USA) or endothelial cells marker vWF (Von Willebrand factor, mouse anti-human, BD
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Biosciences, USA ), or melanoma (gp100) Ab-3 (Ab-3 is a mixture of Ab-1 (HMB45) and Ab-2
(HMB50) antibodies which are extremely sensitive and recognize differentiating melanocytes
and melanomas, Lab Vision- Neomarkers, USA) – for 1 hour and subsequent extensive
washing in PBS. Then sections were incubated in a mixture of secondary antibodies Alexa488-
conjugated donkey anti-mouse and Alexa594-conjugated donkey anti-rabbit or Alexa488-
conjugated donkey anti-rabbit and Alexa594-conjugated donkey anti-mouse (Molecular
Probes, USA) (1µg/ml in PBS). Cell nuclei were counterstained with DAPI (Molecular Probes,
USA). Images were obtained using Zeiss Axiovert 200M microscope equipped with CCD
camera AxioCam HRc and Axiovision software (Zeiss, Germany) and further processed using
Adobe PhotoShop software (Adobe Systems, USA).
We assessed the areas occupied by the T-cadherin-positive melanoma cells using MetaMorph
5.0 (Universal Imaging) and Adobe PhotoShop software (Adobe Systems). In a field of view,
we determined the T-cadherin-positive areas and normalized to the DAPI-stained area unit of
each section. For the quantification, T-cadherin-positive areas were counted in 4-5 fields of
view (1.107 mm2) on 10 random sections for each sample at 100x total magnification (10x
objective).
In the normal skin T-cadherin was abundantly expressed in basal keratinocytes, in differenti‐
ating keratinocytes, in the stromal cells and in all blood vessels located in the underlying derma
(Fig.1).
Figure 1. Double immunofluorescent staining of normal skin samples with antibodies against T-cadherin (red) and
vWF (green). T-cadherin expression was detected in the basal keratinocytes, suprabasal layers, stromal cells and in the
blood vessels (colocalization of T-cadherin and vWF is showed by the arrow). Nuclei were counterstained with DAPI
(blue). Bars, 100 µm.
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The immunofluorescent staining with gp 100 antibodies demonstrated that differentiating
melanocytes were located beneath the layer of epidermal basal keratinocytes and extended
their processes over keratinocytes (Fig. 2A). We were able to show the expression of T-cadherin
in differentiating melanocytes by the overlay of green and red fluorescence (Fig. 2A, B and C)
and in mature melanocytes by mapping the red fluorescence that revealed T-cadherin
expression (Fig. 2C) with a phase-contrast image where the dark cells corresponded to mature







Figure 2. Double immunofluorescent staining of normal skin samples with antibodies against T-cadherin (red) (A, B, C)
and gp 100 (green) (A, B). Figure D depicts phase contrast image. Figures B, C, D represent parallel frozen sections of
the same sample. Differentiating melanocytes (green fluorescence in A, B) and mature melanocytes (phase contrast
image with dark cells in D and corresponding immunofluorescent staining against T-cadherin – red fluorescence in C)
all express T-cadherin. Nuclei were counterstained with DAPI (blue). Colocalization of T-cadherin and gp 100 is
showed by the arrow. Bars, 100 µm.
Previous studies demonstrated that T-cadherin expression is reduced during cancer progres‐
sion. Thus, we examined T-cadherin expression in melanoma samples of patients undergoing
surgical treatment. Consequent cryosections of 10 tissue samples of the primary human
melanoma and 12 samples of visceral metastasis, including two cases of primary melanoma
that developed metastasis within a year were double immunostained with antibodies against
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melanoma cell marker gp 100, T-cadherin, endothelial cell marker vWF and analyzed using
fluorescent microscope.
The tissue staining with subsequent image analysis showed that in the primary melanoma 60%
of the sections was occupied by melanoma cells uniformly expressing T-cadherin (Fig.3A),
while 30% of the sections contained areas with heterogeneous, mosaic pattern of T-cadherin
expression where some melanoma cells were T-cadherin positive and some cells - T-cadherin
negative (Fig.3B and 3C), and the rest 10% exhibited no T-cadherin expression.
  B C
50 µm 
Figure 3. Double immunofluorescent staining of the primary melanoma sample with antibodies against T-cadherin
(red) (A, B, C) and vWF (green) (A, B) or gp 100 (green) (C). Nuclei were counterstained with DAPI (blue). Blood vessels
that expressed T-cadherin are showed by the arrow in A, blood vessels with no T-cdherin are marked by an empty
arrow in B. Bars, 50 µm.
Tumor growth and progression require blood supply. There are three mechanisms by which
solid tumors acquire their blood supply. First, tumor and the surrounding stromal cells secrete
angiogenic factors that stimulate vessel growth and recruitment into the tumor from the
preexisting vessels in a well described process of angiogenesis (Folkman et al., 1971; Folkman
et al., 1992, Folkman 1995). Asahara and colleagues demonstrated the incorporation of
circulating endothelial progenitors form the peripheral blood into sites of ischemia-induced
angiogenesis (Asahara et al., 1997). Beyond these two mechanisms, aggressive primary and
metastatic melanomas are capable of generating microcirculatory channels composed of
extracellular matrix and lined by tumor cells that express VE-cadherin (Hendrix et al., 2001;
Maniotis et al., 1999). These vascular channels (lacunas) allow blood flow. However, lacunas
are not strictly vasculogenic or angiogenic because they are formed by melanoma cells (Folberg
et al., 2002; Maniotis et al., 1999). Therefore the name “vasculogenic mimicry” was assigned
to the process by which melanoma cells generate non-endothelial cell-lined channels (Maniotis
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et al., 1999). This vasculogenic mimicry adds challenges to the practical surgery and requires
new cancer diagnostic and treatment strategies.
Our data indicate that the areas devoid of T-cadherin in the primary melanomas were more
intensively vascularized than the areas with high level of T-cadherin expression. 80% of vWF-
positive blood vessels also expressed T-cadherin (arrows in Fig.3A), while no T-cadherin could
be detected in the rest of the blood vessels (arrows in Fig.3A, 4A). Besides vWF-positive blood
vessels in the primary melanomas (Fig.4A) and in the visceral metastasis, vascular channels
devoid of endothelial cells were found. Interestingly, vascular channels were lined up by the
cells expressing T-cadherin (Fig.4A, C).
 
B C
50 µm 50 µm 
50 µm 
Figure 4. Double immunofluorescent staining of the primary melanoma (A) and visceral metastasis samples (B, C) with
antibodies against T-cadherin (red) and vWF (green). (A) Large lacuna can be seen in the center of the image of the
primary melanoma (showed by an arrow). The walls of the lacunas in the primary melanomas (A) and metastasis (B, C)
were lined up by T-cadherin positive melanoma cells (red). Blood vessels of the primary melanomas and metastasis
were heterogeneous. In (A) vWF-positive blood vessels with no T-cadherin expression could be seen located in the
immediate vicinity of the lacuna (green) fluorescence, marked by an empty arrow in A): in (B and asterisk in C) both
variants of vWF-positive blood vessels are presented: T-cadherin positive and T-cadherin negative (arrows in A and C,
respectively). Nuclei were counterstained with DAPI (blue). Bars, 50 µm.
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Our data indicated that T-cadherin expression in human melanoma was gradually reduced
upon melanoma progression. While nearly 60% of melanoma cells in the primary melano‐
mas expressed T-cadherin,  30% of  the sections exhibited a mosaic pattern of  T-cadherin
expression in melanoma cells and 10% of the sections were T-cadherin negative. In metasta‐
sis, 60% of the sections were occupied by melanoma cells with heterogeneous T-cadherin
expression (mosaic pattern) and the number of T-cadherin-positive cells was reduced to 30%
(Fig. 5). These results were in agreement with the data obtained by Kuphal (Kuphal et al.,
2009) who detected T-cadherin expression in melanocytes in the healthy skin and intratumor‐
al capillaries of the primary melanoma samples while T-cadherin expression was lost in
melanoma cells.
The same pattern was previously described for pre-cancer skin lesions and non-melanoma
skin cancer: T-cadherin expression was gradually lost upon malignization. The aberrant
expression of T-cadherin was also detected in the blood vessels and correlated with the
histological features and invasive behavior of more aggressive tumors (Rubina et al., 2012).
Figure 5. Loss of the expression of T-cadherin in melanocytes during metastasis.
To elucidate the potential role of T-cadherin in melanoma progression and growth, we used
an established model of highly aggressive murine melanoma B16F10 in BDF1 mice. The murine
melanoma B16F10 with lung metastases is considered as an adequate model for testing the
efficacy of new anticancer therapies in preclinical evaluations and the forecasting model of
human disseminated melanoma in anticancer screening (Teicher and Andrews, 2004).
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5. The effect of T-cadherin expression on melanoma cell proliferation and
apoptosis
To assess the effect of T-cadherin expression on melanoma cell proliferation we generated
stable cell lines of murine malignant melanoma B16F10 cells (ATCC® №CRL-6475™) by
transfecting the cells with pcDNA-Tcad using Lipofectamine™ 2000 reagent (Invitrogen, USA.
As a control, luciferase cDNA fragment in the antisense orientation was cloned into the pcDNA
3.1 vector. The cells were cultured and transfected as described before (Yurlova et al., 2010).
For stable cell line generation transfected cells were cloned and selected by incubation with 2
mg/ml G418 (Invitrogen, USA). For some experiments we also used the polyclonal mouse
melanoma B16F10 cell cultures obtained after transfection and subsequent selection with G418
without cloning. Expression of T-cadherin in polyclonal mouse melanoma cell cultures and
melanoma cell clones was examined by Western blotting. Three clones of B16F10 melanoma
cells with different level of T-cadherin expression was chosen: a control clone with no T-
cadherin (T-), clone with low T-cadherin expression (T+) and clone with high T-cadherin
expression (T++) (Yurlova et al., in press).
To investigate the effect of T-cadherin expression on melanoma cell proliferation, cells were
seeded on 6-well plates and harvested by trypsinization after 24, 48 and 72 h in culture and
counted with the Countess® (Invitrogen, USA). After 3 days, the number of T-cadherin-
expressing cells (T+ and T++) was 44-48% higher compared to the control (Fig. 6A). We obtained
similar results using the impedance measurement with xCELLigence system: the cell index
was continuously monitored with 1 min interval for 5 hrs and with 10 min interval for 96 hrs.
(Fig. 6B). The xCELLigence system (Roche, USA) monitors cellular events in real time and
measures electrical impedance across microelectrodes integrated on the bottom of E-Plates.
Thus, our data indicated that T-cadherin expression in mouse B16F10 melanoma cells in‐
creased their proliferation in vitro.
Figure 6. T-cadherin expression stimulated proliferation of B16F10 cells in vitro. (A) Cells were incubated in RPMI 1640
medium containing 10% FBS for indicated periods of time, harvested and counted using CellCounter. (B) The cell pro‐
liferation assay was performed with xCELLigence system. Attachment of 5000 cells per chamber was monitored with
the impedance measurement of the xCELLigence System for 96 hrs. The cell indexes of B16F10 T- (control cells, black),
T+ (cells with low level of T-cadherin, blue) and T++ (cells with high level of T-cadherin, red) are shown. Results are
presented as the means ± SEM of three independent experiments.
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To evaluate the effect of T-cadherin expression on apoptosis of B16F10 cells we performed
staining with Annexin V. The B16F10 cell clones were resuspended in 200 µl of Annexin V
binding buffer (BD Biosciences, USA), incubated with 5 µl of Annexin V-Phycoerythrin (BD
Biosciences, USA) and 10 µl of 7-AAD (BD Biosciences, USA) for 15 min in the dark. The
percentage of apoptotic cells was evaluated by flow cytometry (FACSCanto II™, BD Bioscien‐
ces, USA). The fraction and absolute number (data not shown) of apoptotic and dead cells in
T-cadherin-expressing clones were not significantly different from the control.
Thus, in contrast to the earlier study by Kuphal (Kuphal et al., 2009) who found no effect of T-
cadherin expression on human melanoma cell proliferation, the current study showed that the
expression of T-cadherin in mouse melanoma cells stimulated their proliferation in vitro and
had no effect on the apoptosis.
6. Effect of T-cadherin expression on tumor growth and metastatic
potentials of B16F10 clones in vivo
Animal studies were conducted according to the guidelines of the Institutional Animal Care
and Use committee of Cardiology Research Center (permit number 385.06.2009). In order to
establish a relationship between T-cadherin expression level and increased proliferation of
melanoma cells and melanoma growth in vivo, we injected the clones of B16F10 cells with
different level of T-cadherin expression into BDF1 mice. 1х106 B16F10 cells (T-, T+, or T++
clones) in 0.3 ml of serum-free media were injected subcutaneously in BDF1 mice (n=11 in each
group). 28 days after the injection, animals were sacrificed and primary tumors and lungs were
collected. The measurement of the tumors was performed 4 times a week over 28 days. The
tissue samples were embedded in Tissue-Tek (Sakura, USA), frozen in liquid nitrogen and
stored at -80°C. The cryosections (6 µm) were fixed in 4% formaldehyde. To analyze the
necrosis areas, cryosections were stained with Mayer's hematoxylin. Vascularization and
stroma content was analyzed using the following primary antibodies: anti-T-cadherin, anti-
CD31 to visualize endothelial cells (1:100, BD Biosciences, USA), anti-NG2 to visualize
pericytes (1:100, Abcam, USA), anti-CD90 to visualize MSCs (1:100, BD Biosciences, USA). For
negative controls, non-specific IgGs were used in similar concentration. Cell nuclei were
counterstained with DAPI (Sigma-Aldrich, USA). The sections were analyzed using Leica
AF6000 microscope and MetaMorph 5.0 (Universal Imaging, USA). For statistics, five view
fields on five random sections for each tumor sample were used. The blood vessels were
separated into three groups: capillaries (CD31-positive vessels without lumen and with length
<20 µm); medium vessels (CD31-positive vessels with length 20-40 µm), and large vessels (with
diameter >40 µm). The contribution of the stroma into the growth of primary tumor was
determined as the area of CD90-positive cells in a field normalized to the DAPI-stained area
of each cryosection. To evaluate the necrosis area we calculated the number of cryosections
containing necrosis foci and normalized it to the total number of assessed sections.
The growth kinetic of tumors was compared within the next 4 weeks and then the histopa‐
thology was studied. The T+ and T++ B16F10 cells generated tumors 2.5 and 3 times larger than
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control B16F10 cells, correspondingly (Fig. 7A). Difference between the control and T-
cadherin-expressing tumor volumes was statistically significant. The histological analysis
showed that tumors formed by the control and T-cadherin-expressing B16F10 clones had
different morphology. The tumors generated by the T-cadherin-expressing melanoma clones
contained wider areas of necrosis (Fig. 7B).
We also compared the spontaneous metastatic potential of the B16F10 clones. 28 days after
injection, tumor-bearing mice were sacrificed and their lungs were analyzed. We found that
T-cadherin overexpression enhanced spontaneous metastatic activity of B16F10 cells. The
B16F10 clones with high level of T-cadherin (T++) formed metastasis in 54.5% cases in com‐
parison to 18.2% and 9.1% formed by T+ and T- cells, respectively. Taken together, these results
suggested that the expression of T-cadherin stimulated growth of the primary tumors in vivo
and enhanced their invasion and metastatic potential.
 (a) (b) 
) 
Figure 7. T-cadherin expression in B16F10 cells stimulates tumor growth in vivo. (A) 1х106 of B16F10 cells (T-, T+, or T+
+) were injected subcutaneously in BDF1 mice (n=11). The tumor volume was measured every 3 day after the tumor
cell inoculation. Data represent the mean ± SEM. (B) The necrosis area was calculated as the number of cryosections
containing necrosis foci normalized to the total number of sections. Results are the means ± SEM, p<0.05.
7. Effect of T-cadherin expression on tumor vascularization
Because T-cadherin was shown to inhibit angiogenesis in some models (Rubina et al., 2007)
we examined the effect of T-cadherin on the neovascularization of B16F10 primary melanoma
sites. For that, cryosections of primary melanomas were stained with anti-CD31 antibody to
visualize endothelial cells in the blood vessels penetrating the tumor. The quantitative
evaluation revealed a 1.3-1.5-fold decrease in the number of medium size vessels and 1.5-2-
fold reduction in capillaries in T-cadherin-expressing primary melanomas compared to the
control (Fig. 8). There was no detected difference in the amount of large or stable vessels using
double immunofluorescent staining with anti-CD31 and anti-NG2 (marker of pericytes and
smooth muscle cells) antibodies (data not shown).
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Similar results were obtained using melanoma primary tumors formed by polyclonal mouse
melanoma cell culture (data not shown). We concluded that the effects of T-cadherin were not























Figure 8. T-cadherin expression in B16F10 cells caused the reduction in tumor vascularization. 28 days after the mela‐
noma cell inoculation, sections of primary tumors formed by the B16F10 T-, T+ or T++ cells were stained with anti-
CD31 and anti-T-cadherin antibodies. The quantitative assessment of the blood vessels from 30 random fields of five
independent tumors is presented. The results are the means ± SEM of three independent experiments, p<0.05.
These results suggested that T-cadherin overexpression in B16F10 melanoma cells suppresses
tumor neovascularization by limiting tumor neoangiogenesis.
8. Effect of T-cadherin expression on host stroma
Over the past decade it was discovered that heterogeneous population of progenitor cells
known as multipotent stromal cells or mesenchymal stem cells (MSCs) derived from the bone
marrow or adipose tissue exhibited a marked tropism for tumors (Klopp et al., 2011). Circu‐
lating in the blood stream, MSC from the bone marrow or resident mesenchymal stromal cells
could engraft within the tumor microenvironment and incorporate into the stroma of solid
tumors as tumor-associated fibroblasts and contribute to the growth of the primary tumor sites
(Mishra et al., 2008; Spaeth et al., 2008). MSCs can also act as pericytes-like cells and potentiate
tumor growth, vascularization and metastasis. The mechanism by which MSCs support the
tumor growth and progression is in the intercellular interactions with tumor cells and the
release of the paracrine signals (Spaeth et al., 2009). MSCs themselves are likely to respond to
chemoattractants similar to many immune cells that migrate to injury or inflammation site
(Spaeth et al., 2008).
To examine whether T-cadherin expression influences the recruitment/proliferation of stromal
cells in the model of mouse melanoma growth and progression, cryosections of primary tumor
sites were stained with anti-CD90 antibody to visualize the activated stroma (Campioni et al.,
2008) (Fig. 9A). Immunofluorescent analysis revealed a 2.4–2.9-fold increase in the CD90
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positive areas in the T-cadherin-expressing tumor samples compared to the controls (Fig.
9B). CD90-positive cells were arranged in a form of cell aggregates among the tumor cells or
located perivascular around CD31-positive vessels structures. Thus, for the first time we
revealed that the expression of T-cadherin stimulated the recruitment of CD90-positive cells
to the primary tumor site. The CD90-positive cells were represented mainly by MSCs.
However, some populations of neutrophils, T cells and monocytes could also express CD90
and be recruited to the tumors (Rege and Hagood, 2006).
To support the in vivo data on the T-cadherin-mediated recruitment of the stromal cells to
the growing tumor, we established a transwell assay in which MSCs were co-cultured with
the melanoma clones with different T-cadherin expression. The transwell system allowed
exchange of the medium in the absence of direct interaction between cells in the lower and
upper chambers. The MSCs were isolated from subcutaneous adipose tissue of the ingui‐
nal region of CBA/C57BL male mice and cultured until the 2nd passage as described before
(Rubina et al., 2009). To assess the effect of T-cadherin expression in melanoma cells on their
ability to induce MSC migration, MSCs were seeded in the upper chamber and melanoma
cell clones were seeded in the lower chamber. The MSCs were allowed to migrate across the
collagene-covered membrane and the conditioned medium from the B16F10 clones served
as a chemoattractant. We found that migration of MSCs towards the conditioned medium
from the T++ B16F10 cells was at least 1.5-fold higher than towards the T+ or T- B16F10 cells
(Fig. 10).
We did not detect the shedding of T-cadherin into the conditioned medium from the T-
cadherin expressing B16F10 clones using Western blotting (data not shown). Thus, we
suggested that the observed effects on MSCs migration were mediated by secretion of
chemoattractants and growth factors into the conditioned medium by the T-cadherin express‐
ing melanoma cells. To prove that we studied the expression of angiogenec factors, extracel‐
lular matrix proteins, adhesion molecules and chemokines using the PCR Array assay
(SABiosciences, USA) and quantitative PCR.
9. T-cadherin expression changes the gene expression pattern in B16F10
melanoma cells
For PCR Array assay, total RNA was isolated from B16F10 clones using RNeasy Mini kit. 1
µg of total RNA was treated with DNase, cDNA was prepared using RT2 First Strand kit
(SABiosciences, USA). For each experiment, cDNA sample was mixed with RT2 qPCR Master
mix and distributed across the PCR array 96-well plates. After cycling with real-time PCR
(IQ5 PCR platform, Bio Rad, USA), obtained amplification data (fold-changes in Ct values)
was analyzed with SABiosciences software. RNA expression of each gene was normalized
using 5 housekeeping genes. The relative expression of each gene, compared to expression
in the control B16F10 clone was calculated on the website using ∆∆Ct method. A gene was
considered as differentially regulated if the difference was >2-fold compared with the control
clone.
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For quantitative PCR the RNeasy Mini Kit (Qiagen, Germany) was used to extract the total
RNA. cDNA were prepared using the RevertAid H Minus First Strand cDNA Synthesis Kit
(Fermentas, USA). The primers were obtained from Sintol (Russia). Real-time qPCR analysis
was performed with SYBR Green I on Rotor – Gene™ 3000 (Corbett Research, UK). The gene
expression was normalized to the expression of β-actin and GAPDH. The primer specificity
was confirmed by melting curve analysis. The qRT-PCR was repeated five times.
We performed quantitative PCR and PCR Array Assay of melanoma cells and revealed that
T-cadherin expression in B16F10 melanoma cells resulted the increase in expression of
chemokines CXCL10, CCL5, CXCL11 and CCL7, which were earlier implicated in the growth
and metastasis of different neuroectodermal tumors (Somasundaram and Herlyn, 2009). In a
screen of several human and mouse melanoma cell lines, it was detected that the expression
of chemokine receptors CCR7, CCR10, CXCR1, CXCR2 and CXCR4 could dramatically
increase the rate of metastases (Longo-Imedio et al., 2005; Simonetti et al., 2006; Singh et al.,
2009; Wiley et al., 2001). In the present study, the up-regulation of CXCL10, CCL5, CXCL11
and CCL7 genes was found to be correlated with the increase in spontaneous metastatic activity




B16F10 T++ B16F10 T- B16F10 T+ 
Figure 9. The effect of T-cadherin expression in B16F10 cells on MSC recruitment. (A) 28 days after melanoma cell
inoculation, sections of the primary tumor formed by the B16F10 T- (left), T+ (middle), or T++ (right) cells were stained
with anti-CD90 (red) and with anti-T-cadherin (green) antibody. Bars - 100 µm. (B) The contribution of the stroma into
the growth of primary tumor was determined as an area of CD90-positive cells in a field normalized to the DAPI-
stained area unit of each cryosection using program MetaMorph 5.0. Results are the means ± SEM of three independ‐
ent experiments, p<0.05.
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In normal conditions, the blood vessel growth is strictly controlled by the balance between
pro-angiogenic  and and anti-angiogenic  factors.  At  the same time,  tumor progression is
accompanied by neoangiogenesis due to enhanced production of pro-angiogenic molecules































Figure 10. The effect of conditioned medium from the B16F10 cell clones with different T-cadherin expression on mi‐
gration of MSCs. Migrated MSCs were quantified after fixation and hematoxylin staining of the membrane. The results






GAPDH 60 GACCCCTTCATTGACCTCAACTAC TGGTGGTGCAGGATGCATTGCTGA
β-actin 61 AGTGTGACGTTGACATCCGTA GCCAGAGCAGTAATCTCCTTCT
VEGF А 60 AGAGCAGAAGTCCCATGAAGTGA TCAATCGGACGGCAGTAGCT
PDGF В 58,5 TCTCTGCTGCTACCTGCGTCTGG GTGTGCTCGGGTCATGTTCAAGTC
HGF 60 TCATTGGTAAAGGAGGCAGCTATA CTGGCATTTGATGCCACTCTTA
MMP2 53 AGTTCCCGTTCCGCTTCC GACACATGGGGCACCTTCTG
EGF 60 CCTGCCCCCTTCCTAGTTTTC CTCCGTTCTGTTGGTCTACCC
uPAR 60 CGTTACCTCGAGTGTGCGTCCTG AGCCTCGGGTGTAGTCCTCATCCT
c-Met 60 CAACGAGAGCTGTACCTTGACCTTA GCGGGACCAACTGTGCAT
uPA 53 GAATGCGCCTGCTGTC AGGGTCGCTTCTGGTTGTC
MMP9 61 GCGGTGTGGGGCGAGGTG CCAGGGGGAAAGGCGTGTG
Table 1. Sequences of primers used in qRT-PCR.
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responsible for T-cadherin-mediated suppression of angiogenesis in primary melanoma we
performed qRT PCR and PCR Arrays. No difference in the mRNA expression level of the
main angiogenic growth factors such as VEGF А, HGF, bFGF,  EGF, PDGF B,  TGFβ be‐
tween control and T-cadherin-expressing clones was revealed. However, PCR Array analysis
revealed that T-cadherin expression in B16F10 cells resulted in upregulation of mRNA of
such antiangiogenic molecules as CXCL 10 (Strieter et al., 1995); angiopoietin 2 (Cao et al.,
2007);  procollagen  type  XVIIIα1  -  a  precursor  of  the  angiogenesis  inhibitor  endostatin
(O'Reilly et al., 1997) and chromogranin A - a precursor of angiogenesis inhibitor vasosta‐
tin-1 (Belloni et al., 2007). Angiopoietin 2 acts together with VEGF A in initiating blood vessel
growth through inhibition of the interactions between endothelial and perivascular cells and
destabiliziation  of  blood  vessels.  However,  in  the  absence  of  VEGF  A,  angiopoietin  2
suppresses angiogenesis and promotes vessel regression (Holash et al., 1999). Since in the
present study VEGF A level was not changed after the expression of T-cadherin, the elevated
angiopoietin 2 expression could act in reducing the number of newly formed vessels. We
also found that the T-cadherin-expressing B16F10 cells demonstrated decreased expression
of angiogenic molecules TGFα (Leker et al., 2009) and Tie 1 (Sato et al., 1995). Thus, the PCR
Array analysis indicated that the balance between the pro-angiogenic and anti-angiogenic
factors was shifted towards the latter, which could reduce the number of medium size vessels
and capillaries in vivo.
It is well known that MSCs secrete many growth factors and cytokines and their production
increases in hypoxic conditions (Rubina et al., 2009; Martin-Rendon 2007). Among them is
HGF/SF, which is a potent stimulator of DNA synthesis and growth in normal human
melanocytes and melanoma cells (Halaban et al., 1993). Thus, it was shown that overexpression
of the proto-oncogene c-Met (HGFR - HGF receptor) is tightly correlated with human mela‐
noma progression from the radial to the vertical stage (Natali et al., 1993). In the present study
we found that control B16F10 melanoma cells expressed low levels of c-Met and no HGF. Our
quantitative PCR analysis demonstrated that T-cadherin overexpression resulted in 6-fold
increase in the content of c-Met mRNA in melanoma cells. This data suggested that one of the
mechanisms by which T-cadherin could be able to affect the growth of B16F10 melanoma cells
is the regulation of c-Met/HGF signaling pathway. We speculated that the melanoma cells
expressing T-cadherin could secrete the high levels of chemokines resulting in MSCs recruit‐
ment to the primary tumor site. MSCs in hypoxic conditions are known to increase the
production of HGF (Rubina et al., 2009). Thus, in hypoxic conditions of the primary tumor the
recruited MSCs could produce the high levels of HGF, which upon binding to c-Met on
melanoma cells could cause their increased proliferation and invasion
Apparently, invasive and metastasizing cancers are characterized by the change in integrin
expression pattern (Makrilia et al., 2009). Thus, the overexpressions of integrins such as α3,
α5 and α1 or their single subunits were shown to be involved in melanoma growth and
progression (Kuphal et al., 2005). So we compared the expression level of certain integrins in
the control and T-cadherin expressing melanoma cells using PCR Array. We revealed the
upregulation of mRNA expression of α5, αV, αE, and β3 integrins upon T-cadherinsion. This
correlated with the increase in the metastatic activity of those cells and possibly contributed
to melanoma progression.
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It was shown that the overexpression of some integrins can induce matrix metalloproteinases
(MMPs) expression in melanoma cells or their activation (Khatib et al., 2001; Sil et al., 2011).
Several MMPs including MMP-1, -2, -3, -7, -9, -13, -14, -15, -16 as well as uPA were implicated
in human melanoma progression, invasion and metastasis (Bianchini et al., 2006; Ria et al.,
2010). Using qRT-PCR we examined the expression of mRNA of MMPs with gelatinase activity
and uPA. No differences in MMP2, MMP9 and uPA expression in the control and T-cadhering
positive B16F10 cell clones were revealed. Further PCR The array analysis established that
MMP14 was the only protease with enhanced expression detected in the T-cadherin expressing
clone T++.
Melanoma cells express multiple isoforms of laminin that were shown to mediate cell attach‐
ment and invasion via integrin receptors using laminin as a substrate (Oikawa et al., 2011). In
addition, expression of fibronectin was correlated with the acquisition of invasive and
metastatic behavior of human melanoma (Gaggioli et al., 2007). Using PCR Array analysis we
found that T-cadherin overexpressing melanoma cells exhibited the elevated level of fibro‐
nectin 1 and laminin α3 expression suggesting their role in the increased metastatic potential
of these cells. The obtained data indicated that T-cadherin expression affects the expression of
certain genes involved in regulation of melanoma growth and progression.
In contrast to the results obtained in the present study, the re-expression of T-cadherin by stable
transfection in human melanoma cells reduced the rate of tumor growth in the nu/nu mouse
tumor model, decreased cell capacity for anchorage-independent growth, migration and
invasion in vitro, while cell proliferation was not affected (Kuphal et al., 2009).This discrepancy
could be due to the differences in the experimental conditions of the models (highly aggressive
murine melanoma B16F10 in the BDF1 mice versus human melanoma cells injected into
immunodeficient nu/nu mice). The difference could also be explained by the distinct signaling
pathways and spectrum growth factors and receptors expressed by mouse and human
melanoma.
10. Conclusions
In the present study, we found that T-cadherin is expressed in normal epidermal keratinocytes,
vascular cells of the dermal blood vessels and melanocytes in the human skin. However, upon
malignant transformation we observed mosaic pattern of T-cadherin expression in primary
melanomas and partial or complete loss of T-cadherin in melanoma metastasis. These data are
in accordance with the earlier published results and confirmed the correlation between tumor
progression and the loss of T-cadherin expression. It was previously reported that 80% of the
human melanoma cell lines did not express T-cadherin and re-expression of T-cadherin
reduced the tumorigenicity of these cell lines in nu/nu mouse model. However, 20% of human
melanoma cell lines abundantly expressed T-cadherin and possessed invasive and metastatic
potential. This prompted us to use a well-described model of highly aggressive murine
melanoma B16F10 in BDF1 mice and examine the effect of T-cadherin expression in melanoma
cells on their proliferation, tumor growth, invasive and metastatic potential and neovascula‐
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rization. We showed that overexpression of T-cadherin in melanoma B16F10 cells resulted in
the increased tumor growth and metastasi as well as the recruitment of MSC into the primary
site. We suggested that in response to the chemoattractants (chemokines) produced by the T-
cadherin-expressing tumors, the stromal cells migrated into the primary site and produced
HGF. In return, HGF triggered the HGF/c-Met signaling cascade in T-cadherin-expressing
melanoma cells that could lead to their increased proliferation and metastasis. The elevated
expression level of prooncogenic integrins, the extracellular matrix components and MMP14
in these cells could be contributing factors to enhanced metastatic and invasive potential.
However, T-cadherin expression in melanoma cells exerted inhibitory effect on vascularization
of the primary tumors, which is likely to be due to the switch in the balance of pro- and
antiangiogenic molecules. The established link between the expression of T-cadherin and
pathological processes that trigger neovascularization and tumor progression are particularly
important in search for new approaches for inhibiting metastasis of the less curable tumors
such as disseminated melanoma of the skin. Further investigations studies are needed to
identify the role of T-cadherin in the initiation of tumor progression associated with the
regulation of neoangiogenesis. Our studies provided new evidence on the role of tumor
microenvironment and will help to identify the critical points for suppressing the blood supply
at the early stages of tumor progression. We concluded that the expression of T-cadherin in
melanoma cells underlies a novel mechanism of stem cell tropism to malignant solid tumors,
which may be important for the development of the optimal stem cell-based therapy. Inves‐
tigation of such mechanisms is an important task in finding new targets for cancer treatment.
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